PSP Research »

Trevi Therapeutics shares owned by PSP Research

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by PSP Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $358k 30k 11.93

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust State Street Spd (XBI)
Sera Prognostics Class A Com (SERA)
Definium Therapeutics Com Shs (DFTX)
Tyra Biosciences (TYRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Pharvaris N V (PHVS)
Cytokinetics Com New (CYTK)
Royalty Pharma Shs Class A (RPRX)
Kymera Therapeutics (KYMR)
Halozyme Therapeutics (HALO)
Exelixis (EXEL)
Disc Medicine (IRON)
Ionis Pharmaceuticals (IONS)
Agios Pharmaceuticals (AGIO)

View all positions for PSP Research

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
BlackRock
FMR
Vanguard Group
Vivo Capital
Marshall Wace
Rubric Capital Management
Wellington Management Company
MPM Oncology Impact Management
Viking Global Investors
OrbiMed Advisors
Alliancebernstein
Octagon Capital Advisors
Eventide Asset Management

View all funds holding Trevi Therapeutics